Case Western Reserve: Medicine's Justin Lathia Receives 2026 ASPIRE Award to Examine Potential Treatments for Aggressive Brain Cancer
March 07, 2026
March 07, 2026
CLEVELAND, Ohio, March 7 -- Case Western Reserve University issued the following news:
* * *
Medicine's Justin Lathia receives 2026 ASPIRE Award to examine potential treatments for aggressive brain cancer
Justin Lathia, PhD, professor of molecular medicine at Cleveland Clinic Lerner College of Medicine and co-leader of Case Comprehensive Cancer Center's Molecular Oncology Program, recently received a 2026 ASPIRE Award from The Mark Foundation for . . .
* * *
Medicine's Justin Lathia receives 2026 ASPIRE Award to examine potential treatments for aggressive brain cancer
Justin Lathia, PhD, professor of molecular medicine at Cleveland Clinic Lerner College of Medicine and co-leader of Case Comprehensive Cancer Center's Molecular Oncology Program, recently received a 2026 ASPIRE Award from The Mark Foundation for . . .